Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.70
Bid: 41.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.439%)
Open: 41.70
High: 0.00
Low: 0.00
Prev. Close: 41.70
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BMK08+CleanTreat Update

16 Apr 2021 11:00

RNS Number : 7421V
Benchmark Holdings PLC
16 April 2021
 

16 April 2021

 

Benchmark Holdings

("Benchmark" or the "Company")

 

BMK08+CleanTreatÒ Update

 

Ratification of Maximum Residue Limit under European Law

Significant milestone towards the commercialisation of BMK08 and CleanTreatÒ

 

Further to the notification made on 10 September 2020, Benchmark Holdings is pleased to announce that the MRL (Maximum Residue Limit) for its novel sea lice treatment BMK08 has now been ratified under European Law. The MRL confirms the safety of Benchmark's sea lice solution for consumers and represents a significant milestone in the regulatory approval process towards the anticipated commercial launch of BMK08 and CleanTreatÒ in Norway. The commercial launch remains subject to the grant of a Marketing Authorisation in Norway.

 

BMK08 and CleanTreatÒ is a transformational solution addressing the biggest biological challenge in salmon farming. The MRL EU ratification is the culmination of almost a decade of research and development, a rigorous trial programme and substantial capital investment by Benchmark.

 

Trond Williksen, CEO, commented:

 

"The ratification of the MRL is a further stepping stone towards commercialisation following the announcement of our first customer agreements for CleanTreatâ announced in March.

 

Sea lice continues to be the biggest biological challenge for salmon producers and Benchmark's novel solution addresses this challenge in a sustainable way both in terms of animal welfare and environmental impact."

 

Enquiries:

 

 

Benchmark Holdings plc

Tel: 020 3696 0630

Ivonne Cantu, Investor Relations Director

 

Rachel Aninakwah, Communications

 

 

 

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black / Freddie Barnfield / Duncan Monteith

 

 

 

MHP

 

Katie Hunt /Alistair de Kare-Silver

Tel: 020 3128 8742

benchmark@mhpc.com

 

 

 

 

 

About Benchmark 

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDKABNCBKKAQD
Date   Source Headline
8th Oct 201512:15 pmRNSPotential acquisition and suspension of shares
8th Oct 201512:15 pmRNSSuspension - Benchmark Holdings Plc
30th Sep 20157:00 amRNSSalmoBreed breakthrough
30th Sep 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSBlock Admission Application
27th Jul 20157:00 amRNSAcquisition
13th Jul 20153:40 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHalf Yearly Report
6th May 20155:46 pmRNSHolding(s) in Company
30th Apr 201512:44 pmRNSHolding(s) in Company
29th Apr 20157:00 amRNSTrading Statement
23rd Apr 201512:34 pmRNSHolding(s) in Company
17th Mar 201512:25 pmRNSHolding(s) in Company
10th Mar 20151:13 pmRNSDirector Share Options
5th Mar 201510:43 amRNSResult of AGM
26th Feb 20152:39 pmRNSHolding(s) in Company
16th Feb 20151:51 pmRNSHolding(s) in Company
3rd Feb 201512:59 pmRNSHolding(s) in Company
2nd Feb 20157:00 amRNSAcquisition
27th Jan 20157:01 amRNSFinal Results
8th Jan 20152:21 pmRNSHolding(s) in Company
6th Jan 201510:53 amRNSHolding(s) in Company
19th Dec 20144:32 pmRNSHolding(s) in Company
19th Dec 20144:26 pmRNSHolding(s) in Company
19th Dec 20144:24 pmRNSHolding(s) in Company
19th Dec 20144:20 pmRNSHolding(s) in Company
19th Dec 20144:14 pmRNSHolding(s) in Company
18th Dec 20144:38 pmRNSResult of General Meeting
10th Dec 201412:44 pmRNSProposed Placing and Acquisitions Update
27th Nov 20144:50 pmRNSNotice of Posting of Circular for General Meeting
24th Nov 20147:00 amRNSPlacing & Proposed Acquisitions Replacement
21st Nov 20145:56 pmRNSPlacing, Proposed Acquisitions and Trading Update
1st Sep 20147:00 amRNSHypoPet Agreement
16th Jul 20145:58 pmRNSHolding(s) in Company
4th Jul 20148:03 amRNSHolding(s) in Company
24th Jun 20147:00 amRNSHalf Yearly Report
23rd Jun 20148:45 amRNSHolding(s) in Company
16th May 20147:00 amRNSTrading Update and Notice of Results
12th Mar 20144:05 pmRNSDirector's shareholding
11th Mar 201410:41 amRNSResult of AGM
17th Feb 20147:00 amRNSAcquisition
14th Feb 201410:00 amRNSPosting of Annual Report and Notice of AGM
24th Jan 20146:22 pmRNSAmendment: Issue of Equity
23rd Jan 20144:57 pmRNSIssue of Equity
23rd Dec 20134:57 pmRNSHolding(s) in Company
19th Dec 201312:13 pmRNSHolding(s) in Company
18th Dec 20138:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.